RecruitingNCT03364803

Collecting Information About Treatment Results for Patients With Cushing's Syndrome

Treatment Outcomes for Patients With Cushing's Syndrome: a Prospective Data Collection Study


Sponsor

Memorial Sloan Kettering Cancer Center

Enrollment

300 participants

Start Date

Nov 28, 2017

Study Type

OBSERVATIONAL

Conditions

Summary

The purpose of this study is to follow participants with Cushing's syndrome during the course of their routine care and to form a data registry to study long term participant outcomes.


Eligibility

Min Age: 14 Years

Plain Language Summary

Simplified for easier understanding

This trial is collecting detailed medical information and long-term follow-up data from patients who have Cushing's syndrome — a condition where the body produces too much of a stress hormone called cortisol — to better understand how different treatments affect outcomes over time. **You may be eligible if...** - You are 14 years or older - You have been diagnosed with active or previously treated Cushing's syndrome (caused by a tumor in the pituitary gland, adrenal gland, or elsewhere in the body) - You have a mild form of adrenal Cushing's syndrome, or a silent pituitary tumor that produces too much of a hormone called ACTH - Your diagnosis was made using standard endocrine guidelines **You may NOT be eligible if...** - You are younger than 14 years old - You do not have a confirmed or suspected diagnosis of Cushing's syndrome or a related adrenal or pituitary condition Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERCushing's QoL (Quality of Life Questionnaire)

Cushing's QoL is a validated disease specific questionnaire consisting of 12 questions on a five-point Likert scale ranging from always to never. The total score ranges from 12 to 60, with a lower score indicating a greater negative impact on health related QoL. This is converted to a 0-100 scale, 0 indicating the worst and 100 indicating the best QoL

OTHERNottingham Health Profile (NHP)

NHP is used in patients to assess general health and quality of life. This assessment consists of 38 yes/no questions that are subdivided into six scales assessing impairments: pain (eight items), energy level (three items), sleep (five items), emotional reactions (nine items), social isolation (five items) and physical mobility (eight items). A higher score indicates more impairment

OTHERHospital Anxiety and Depression Scale (HADS)

HADS consists of 14 items pertaining to anxiety and depression, with each item measured on a four-point scale. Total scores for the anxiety and depression subscales range from 0 to 21. A higher score indicates greater symptomatology

OTHERPerceived Stress Scale (PSS)

The PSS predicts both objective biological markers of stress and increased risk of disease in patients with higher stress levels.

OTHERBarratt's Impulsivity Scale (BIS)

BDI and BIS in combination have demonstrated that depression and/or binge eating may be mediating factors for the outcome of obesity

OTHERBeck Depression Inventory (BDI)

BDI and BIS in combination have demonstrated that depression and/or binge eating may be mediating factors for the outcome of obesity

OTHERState-Trait Anxiety Inventory (STAI)

The STAI provides data to help distinguish between anxiety and depression.

OTHERState Food Craving Questionnaire-State (FCQ-S)

The FCQ-S consists of 15 items assessing: desire to eat, anticipation of positive reinforcement from eating, anticipation of negative reinforcement (reduction of negative affect) from eating, lack of control over eating, and (physiological) hunger; higher scores reflect stronger food craving. Participants respond, using a Likert-type scale, how much each item is true of them right now.

OTHERTrait Food Craving Questionnaire-Trait (FCQ-T)

Trait food craving will be assessed with the Food Craving Questionnaire-Trait (FCQ-T). The FCQ-T consists of 39 items assessing: intentions/plans to eat, anticipation of positive reinforcement from eating, anticipation of negative reinforcement from eating, lack of control over eating, preoccupation with food, (physiological) hunger, emotions preceding or following food cravings or eating, environmental cues that may elicit food cravings, negative emotions including guilt experienced as a consequence of food cravings, and/or indulging such cravings; higher scores again indicate higher trait craving. Individuals are asked to respond, using a Likert-type scale, how much each item is true of them in general.

OTHERVisual Analogue Scale (VAS)

A validated visual analogue scale (VAS) questionnaire will be completed in the fasting state. The VAS consists of 100-mm lines with words anchored at each end describing extreme sensations of hunger, prospective consumption ("How much do you think you can eat?"), fullness, and satisfaction, as well as craving (sweet, salty, fatty or savory). Patients will be asked to make a vertical mark across the line corresponding to their feelings. Quantification will performed by measuring the distance from the left end of the line to the mark.

OTHERSensitivity to Reinforcement of Addictive and other Primary Rewards (STRAP-R) food variant

A validated questionnaire that assesses perceived subjective value attributed to expected/hypothetical foods and other primary reinforcers will be administered. This variant of this questionnaire was initially developed by Dr. Goldstein to assess 'liking' and 'wanting' of expected drug rewards for patients with cocaine addiction. The current assessment uses a modified version to assess 'liking' and 'wanting' for food.


Locations(7)

Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)

Basking Ridge, New Jersey, United States

Memorial Sloan Kettering Monmouth (Limited Protocol Activities)

Middletown, New Jersey, United States

Memorial Sloan Kettering Bergen (Limited Protocol Activities)

Montvale, New Jersey, United States

Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Limited protocol activity)

Commack, New York, United States

Memorial Sloan Kettering Westchester (Limited Protocol Activities)

Harrison, New York, United States

Memorial Sloan Kettering Cancer Center

New York, New York, United States

Memorial Sloan Kettering Nassau (Limited Protocol Activities)

Uniondale, New York, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03364803


Related Trials